BackBeiGene Overview

BeiGene Inventory

BeiGene's inventory is $730M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$732.60M
↑ 45.69% YoYΔ $229.74M vs prior year quarter

Peer trimmed avg / median

Loading

BeiGene Inventory History

Loading

BeiGene vs. peers: Inventory Comparison

Loading

BeiGene Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BeiGene (BGNE) FAQ

BeiGene (BGNE) currently reports a inventory of $730M as of June 2026. That compares with $500M in the prior-year period — up 45.7% year over year. Use the charts on this page to explore BeiGene's inventory history and peer comparisons.

BeiGene's inventory increased from $500M to $730M — a 45.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BeiGene reported $730M in inventory as of June 2026. That compares with $500M in the prior-year period — up 45.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $730M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BeiGene, and consider following BGNE for alerts when major investors trade the stock.

BeiGene is classified in the Healthcare sector. On inventory, it currently shows $730M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BGNE with unrelated industries.